Open access · CC-BY
via OpenAlex
Transcriptomic Signatures in Autism Spectrum Disorder: Opportunities and Limitations across Brain, Blood and Saliva
American Journal of Pure and Applied Biosciences · 2026
Abstract
Autism spectrum disorder (ASD) is behaviorally defined yet biologically heterogeneous, which has encouraged interest in transcriptomic readouts that may capture underlying molecular variation. This focused narrative review examines what transcriptomic studies can and cannot currently contribute to ASD research and translation across three principal specimen types: postmortem brain, peripheral blood, and saliva. Evidence from cortical RNA-seq consistently identifies reduced neuronal and synaptic expression programs, altered alternative splicing, and increased immune-glial signatures, while single-nucleus studies refine these observations to specific cell populations. Peripheral blood studies reveal immune-related and cell-composition-sensitive signals, including monocyte- and NK-cell-associated shifts, but their translational value is constrained by small cohorts, preanalytical variability, and limited external validation. A notable non-invasive translational signal comes from salivary small-RNA work, which supports proof of concept for adjunctive biomarker panels rather than stand-alone diagnosis. Across tissues, convergent axes - synaptic dysfunction, immune dysregulation, mitochondrial disturbance, and RNA-processing abnormalities - support biological plausibility, but do not yet establish a clinically deployable transcriptomic test. Platform choice is also consequential: bulk RNA-seq is scalable but insensitive to cellular heterogeneity; single-nucleus RNA-seq provides mechanistic resolution but is not clinically practical; and long-read RNA-seq improves isoform discovery but remains resource-intensive. Current evidence positions transcriptomics primarily as a research tool for mechanistic inference and candidate stratification, with limited but real potential for future adjunctive biomarker development rather than replacement of behavioral diagnosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.34104/ajpab.026.05210528
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Kurmashev, R. (2026). Transcriptomic Signatures in Autism Spectrum Disorder: Opportunities and Limitations across Brain, Blood and Saliva. <em>American Journal of Pure and Applied Biosciences</em>. https://doi.org/10.34104/ajpab.026.05210528
Vancouver
Kurmashev R. Transcriptomic Signatures in Autism Spectrum Disorder: Opportunities and Limitations across Brain, Blood and Saliva. American Journal of Pure and Applied Biosciences. 2026. doi:10.34104/ajpab.026.05210528.
BibTeX
@article{ruslan2026Transc,
title = {Transcriptomic Signatures in Autism Spectrum Disorder: Opportunities and Limitations across Brain, Blood and Saliva},
author = {Ruslan Kurmashev},
journal = {American Journal of Pure and Applied Biosciences},
year = {2026},
doi = {10.34104/ajpab.026.05210528},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Trends in neurosciences 2026
Citation only
Epigenetic noise in the aging brain: tuning neuronal vulnerability to neurodegeneration.
2026
Preprint
Cross-Tissue Inflammatory Convergence Supports a Putative Muscle-Brain Axis in Alzheimer's Disease
Alzheimer's & dementia : the journal of the Alzheimer's Association 2026
Citation only
Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review.
Psychiatry International 2026
Open access · CC-BY
Peripheral Inflammatory Biomarkers in First-Episode, Drug-Naïve Major Depressive Disorder: A Systematic Review
Cell Reports 2025
Open access · CC-BY
Spatial and single-cell transcriptomics reveal the reorganization of cerebellar microglia with aging
Physiological genomics 2026
Citation only